ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.172,28
-0,69%
S&P 500
6.021,63
0,57%
Dow Jones
44.860,31
0,28%
Euro vs US Dollar
1,05217
0,29%
Bitcoin
93.402,47
1,56%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Vincerx Inc (VINC)

  7. Vincerx Inc (VINC) News

VINC

Vincerx (VINC)

Vincerx Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VINC
DatumZeitQuelleÜberschriftSymbolFirma
25/11/202423h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
12/11/202415h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
12/11/202415h00GlobeNewswire Inc.Vincerx Pharma Reports Third Quarter 2024 Financial ResultsNASDAQ:VINCVincerx Inc
05/11/202415h15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VINCVincerx Inc
07/10/202422h05GlobeNewswire Inc.Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate UpdatesNASDAQ:VINCVincerx Inc
30/09/202412h57Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:VINCVincerx Inc
10/09/202422h02Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:VINCVincerx Inc
19/08/202422h01Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:VINCVincerx Inc
16/08/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
15/08/202402h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
15/08/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
13/08/202422h06Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:VINCVincerx Inc
08/08/202422h39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VINCVincerx Inc
08/08/202422h37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
08/08/202422h30GlobeNewswire Inc.Vincerx Pharma Reports Second Quarter 2024 Financial ResultsNASDAQ:VINCVincerx Inc
02/08/202422h01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VINCVincerx Inc
08/07/202422h45Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VINCVincerx Inc
30/05/202403h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
30/05/202403h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
28/05/202422h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
28/05/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
28/05/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
28/05/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VINCVincerx Inc
28/05/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
14/05/202422h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VINCVincerx Inc
14/05/202422h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VINCVincerx Inc
14/05/202422h15GlobeNewswire Inc.Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:VINCVincerx Inc
26/04/202406h27GlobeNewswire Inc.Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and WarrantsNASDAQ:VINCVincerx Inc
25/04/202422h01GlobeNewswire Inc.Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and WarrantsNASDAQ:VINCVincerx Inc
08/04/202422h30GlobeNewswire Inc.Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 NASDAQ:VINCVincerx Inc
 Showing the most relevant articles for your search:NASDAQ:VINC

Kürzlich von Ihnen besucht

BOV
I1QV34Q
Iqvia
BIT
P17XQ5
BNP Paribas Issuance
OKEX
LUNCUSDT
Terra Luna Classic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€